Presentation
Reference
CP068
Status
RUO
Quantity
0.5mg
Application
Agonist of the glycoprotein GPVI (GPVI) receptor platelet activation pathway
Form
Lyophilized peptide
Principle
- Triple helical chain structure with double cross linking.
- Functions as a potent agonist of the Glycoprotein VI (GPVI) receptor.
- Demonstrates high potency for both platelet activation and aggregation.
- Exceptional purity exceeding 99%.
- Consistently reliable from batch to batch.
Download
| Date | Document Name | Download |
|---|---|---|
| CP068-CRP-A-Datasheet-v2026-05 | Datasheet (37.42 KB) |
Bibliography
| Author | Title | Year of edition | Review |
|---|---|---|---|
|
Effect of phosphodiesterase inhibitors on platelet function
|
2025
|
Biochemistry and Biophysics Reports
|
|
|
Dietary saturated fatty acid composition alters the platelet lipid profile and promotes platelet hyperreactivity
|
2025
|
Blood
|
|
|
Megakaryocytes transfer mitochondria to bone marrow mesenchymal stromal cells to lower platelet activation
|
2025
|
The Journal of Clinical Investigation
|